Free Trial

Axiom Investors LLC DE Acquires Shares of 37,772 Integer Holdings Corporation $ITGR

Integer logo with Medical background

Key Points

  • Axiom Investors LLC DE has acquired 37,772 shares of Integer Holdings Corporation, valued at approximately $4.46 million, which represents about 0.11% of the company.
  • Integer Holdings has seen significant institutional interest, with 99.29% of its stock owned by institutional investors and hedge funds, and multiple firms increasing their stakes in the first quarter.
  • Analysts have mixed ratings on Integer, with a consensus rating of "Buy" and a target price averaging $140.25, despite recent downgrades from firms like Wells Fargo and Truist Financial.
  • Need better tools to track Integer? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Axiom Investors LLC DE acquired a new stake in Integer Holdings Corporation (NYSE:ITGR - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 37,772 shares of the medical equipment provider's stock, valued at approximately $4,457,000. Axiom Investors LLC DE owned 0.11% of Integer as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. AdvisorNet Financial Inc acquired a new position in Integer in the 1st quarter valued at $28,000. Opal Wealth Advisors LLC acquired a new position in Integer in the 1st quarter valued at $28,000. Bessemer Group Inc. increased its stake in Integer by 73.1% in the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 125 shares during the period. SVB Wealth LLC acquired a new position in Integer in the 1st quarter valued at $35,000. Finally, Headlands Technologies LLC increased its stake in Integer by 1,234.8% in the 1st quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider's stock valued at $145,000 after buying an additional 1,136 shares during the period. 99.29% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Donald J. Spence sold 14,739 shares of the business's stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the sale, the director directly owned 18,781 shares in the company, valued at $2,260,856.78. The trade was a 43.97% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of the business's stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the transaction, the director directly owned 22,170 shares of the company's stock, valued at $2,672,815.20. The trade was a 28.23% decrease in their position. The disclosure for this sale can be found here. 2.16% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Wells Fargo & Company dropped their price objective on shares of Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. Truist Financial decreased their target price on shares of Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a research report on Friday, July 25th. Citigroup upgraded shares of Integer from a "hold" rating to a "strong-buy" rating and boosted their target price for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Raymond James Financial decreased their target price on shares of Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a research report on Friday, July 25th. Finally, Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $140.25.

View Our Latest Report on ITGR

Integer Price Performance

Integer stock opened at $110.6490 on Friday. Integer Holdings Corporation has a 52 week low of $104.93 and a 52 week high of $146.36. The company has a quick ratio of 2.18, a current ratio of 3.41 and a debt-to-equity ratio of 0.72. The firm's 50-day simple moving average is $113.76 and its 200 day simple moving average is $119.04. The firm has a market capitalization of $3.88 billion, a PE ratio of 48.74, a P/E/G ratio of 0.87 and a beta of 1.02.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a return on equity of 12.27% and a net margin of 4.61%.The business had revenue of $476.00 million during the quarter, compared to analysts' expectations of $464.37 million. During the same quarter in the prior year, the firm earned $1.30 earnings per share. Integer's quarterly revenue was up 11.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, equities research analysts predict that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Integer Profile

(Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Further Reading

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR - Free Report).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Integer Right Now?

Before you consider Integer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.

While Integer currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines